D-Glucose: Uses, Risks and How It Works

D-glucose and D-glucose are two names for the same molecule: the primary sugar the human body uses as fuel. Found naturally in food and circulating in the bloodstream, D-glucose powers cellular respiration and is essential for brain function, red blood cell activity and energy production throughout the body. In UK clinical settings it is often labelled as dextrose on intravenous fluid bags. This article explains how D-glucose works, its medical uses within the NHS, potential risks and side effects, and how common medicines and health conditions can affect glucose regulation.

What is D-glucose and how does it work in the body?

D-glucose is the body's main fuel, absorbed from dietary carbohydrates and converted into ATP energy inside cells. The brain and red blood cells are especially dependent on a continuous supply, and blood glucose is tightly regulated by insulin and glucagon.

D-glucose is the primary sugar the body uses as fuel, circulating in the bloodstream and entering cells to produce energy through a process called cellular respiration. It is the naturally occurring form of glucose found in food and in the human body, and the term 'D' refers to its specific molecular orientation rather than a brand or product name. On UK intravenous fluid labels, D-glucose is often listed as 'dextrose'; the two terms refer to the same molecule. When you eat carbohydrates, digestive enzymes break them down into D-glucose, which is then absorbed through the small intestine into the bloodstream.

Once in the blood, D-glucose triggers the pancreas to release insulin, a hormone that acts like a key, unlocking cells so they can absorb glucose and convert it into adenosine triphosphate (ATP), the body's main energy currency. The brain and red blood cells are particularly dependent on a steady supply of D-glucose: red blood cells have no mitochondria and cannot use alternative fuels, while the brain relies on glucose in the short term, though it can adapt to use ketone bodies during prolonged fasting.^[10] The kidneys also use glucose but, unlike red blood cells, can draw on other fuels such as fatty acids and lactate.

The body maintains blood glucose within a tightly regulated range. NHS guidance indicates that a normal fasting blood glucose level is generally below 6.0 mmol/L, rising to below 7.8 mmol/L two hours after eating. When glucose levels fall too low (hypoglycaemia) or rise too high (hyperglycaemia), the body activates hormonal responses involving insulin, glucagon and adrenaline to restore balance. Excess D-glucose is stored in the liver and muscles as glycogen, or converted to fat for longer-term energy storage. Understanding this regulatory system is central to managing conditions such as type 1 and type 2 diabetes.

What are the side effects and risks I should know about?

Consistently high D-glucose intake raises the risk of hyperglycaemia and long-term complications affecting the kidneys, eyes, nerves and heart. Emergency symptoms such as vomiting, confusion or fruity breath require an immediate 999 call.

Consuming D-glucose in amounts that exceed the body's immediate energy needs carries well-established health risks, particularly when intake is consistently high over time. In healthy individuals, short-term overconsumption may cause a rapid rise in blood glucose followed by a sharp fall, sometimes described colloquially as a 'sugar crash' (more precisely, symptoms suggestive of reactive hypoglycaemia), which can lead to fatigue, difficulty concentrating and increased hunger.

In people with diabetes or impaired glucose tolerance, elevated blood glucose (hyperglycaemia) can cause symptoms including increased thirst, frequent urination, blurred vision and headaches. Persistently high blood glucose is associated with long-term complications affecting the kidneys, eyes, nerves and cardiovascular system, as outlined in NICE guidance on diabetes management.^[3][4] If you develop symptoms that may indicate a serious hyperglycaemic emergency, such as vomiting, abdominal pain, rapid or laboured breathing, confusion, or a fruity smell on the breath (which may suggest diabetic ketoacidosis, DKA) or extreme thirst with drowsiness (which may suggest hyperosmolar hyperglycaemic state, HHS), seek emergency medical attention by calling 999 immediately.

When D-glucose is used as an intravenous (IV) solution in hospital, potential adverse effects include:

• Local reactions at the infusion site, such as pain, redness or phlebitis

• Extravasation (leakage of fluid into surrounding tissue), which is of particular concern with hypertonic glucose solutions and can cause tissue damage^[18]

• Fluid overload, particularly in patients with heart or kidney conditions

• Electrolyte disturbances, including low sodium (hyponatraemia) or low potassium (hypokalaemia), the risk of which varies with the concentration and volume infused, whether insulin is co-administered, and individual patient factors

• Hyperglycaemia if infused too rapidly or in excessive volumes

Suspected adverse reactions to any medicinal glucose product should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. For symptoms of severe hypoglycaemia, such as loss of consciousness or seizures, call 999 immediately. For urgent but non-emergency concerns about blood glucose management, contact NHS 111 or your GP.

Are there any medicines or conditions that affect how D-glucose works?

Corticosteroids, antipsychotics and thiazide diuretics raise blood glucose, while insulin and sulphonylureas lower it and increase hypoglycaemia risk. Beta-blockers can mask palpitations as a warning sign of low blood sugar.

Several medicines and underlying health conditions can significantly alter how D-glucose is absorbed, distributed or metabolised in the body. People with diabetes are the most commonly affected group, as both insulin and oral glucose-lowering medicines directly modify the body's response to circulating glucose.

Medicines that can raise blood glucose levels include corticosteroids (such as prednisolone), some antipsychotics, thiazide diuretics and certain immunosuppressants. Conversely, insulin, sulphonylureas (such as gliclazide) and other antidiabetic agents lower blood glucose and increase the risk of hypoglycaemia if glucose intake is insufficient. Beta-blockers may mask some warning signs of hypoglycaemia, such as a racing heart (palpitations), making it harder to recognise a low blood sugar episode; sweating is generally not masked and remains a useful warning sign. The BNF provides detailed information on medicines that raise or lower blood glucose.

Non-medicine factors can also affect glucose levels significantly. Alcohol can cause hypoglycaemia, particularly in people taking insulin or sulphonylureas.^[6][7] Acute illness tends to raise blood glucose, while strenuous exercise can lower it, sometimes for several hours afterwards.

Conditions that affect glucose metabolism include:

• Type 1 and type 2 diabetes, where insulin production or action is impaired

• Cushing's syndrome, which causes elevated cortisol and secondary hyperglycaemia

• Liver disease, which reduces the liver's capacity to store and release glycogen

• Kidney disease, which can affect glucose reabsorption and the clearance of glucose-lowering medicines

• Hyperthyroidism, which accelerates glucose absorption and turnover

Anyone taking medicines that interact with glucose regulation should discuss monitoring arrangements with their GP or specialist, particularly before making significant changes to diet or starting new treatments. NICE guidelines on type 2 diabetes (NG28) and type 1 diabetes (NG17) provide detailed guidance on managing these interactions safely.^[3][4]

When is D-glucose used medically in the UK?

D-glucose is used in UK hospitals to treat severe hypoglycaemia via intravenous infusion and forms the carbohydrate component of parenteral nutrition. A standardised 75-gram oral glucose drink is also used diagnostically for gestational diabetes screening per NICE guidance.

D-glucose is used medically in the UK primarily to treat hypoglycaemia and to provide nutritional support when a patient cannot eat or drink adequately. In emergency settings, intravenous glucose solutions are administered to rapidly correct dangerously low blood sugar, particularly in unconscious patients or those with severe symptomatic hypoglycaemia. The Joint British Diabetes Societies (JBDS) guideline on the management of hypoglycaemia in adults recommends IV glucose (typically as a 10% or 20% solution) as a hospital treatment when oral or buccal glucose is not possible. IV glucose must only be administered in a clinical setting by trained healthcare professionals and is not suitable for self-administration.

For conscious patients experiencing mild to moderate hypoglycaemia, oral glucose preparations such as glucose tablets or glucose gels are recommended by Diabetes UK and the JBDS as a fast-acting treatment. The standard guidance is to consume 15 to 20 grams of fast-acting carbohydrate, wait 15 minutes, and recheck blood glucose levels before repeating if necessary.^[7]

Beyond hypoglycaemia management, D-glucose is used in the following clinical contexts in the UK:

• Intravenous nutrition (parenteral nutrition): Glucose solutions form the carbohydrate component of parenteral nutrition regimens for patients who cannot absorb nutrients via the gut

• Oral glucose tolerance test (OGTT): A standardised 75-gram glucose drink is used diagnostically. In the UK, type 2 diabetes in non-pregnant adults is diagnosed primarily using HbA1c, with the OGTT reserved for situations where HbA1c is unreliable (for example, in haemoglobin disorders or rapidly changing glucose levels).^[3] The 75-gram OGTT is the standard diagnostic test for gestational diabetes mellitus, in line with NICE guidance (NG3)^[8][9]

• Rehydration solutions: Glucose is included in oral rehydration salts to enhance sodium and water absorption in the gut during illness^[15][16]

If you are unsure whether a glucose-based product is appropriate for your situation, speak to your GP or pharmacist before use. Online weight-management consultations, such as those offered by Bolt Pharmacy, a GPhC-registered UK online pharmacy, may also involve assessment of metabolic health including blood glucose status as part of a broader clinical review.

Scientific References

1. High blood sugar (hyperglycaemia).
2. Diabetes.
3. Type 2 diabetes in adults: management (NG28).
4. Type 1 diabetes in adults: diagnosis and management (NG17).
5. Beta-adrenoceptor blocking drugs – Treatment summaries.
6. A Prospective Trial of Risk Factors for Sulfonylurea-Induced Hypoglycemia.
7. Hypoglycaemia – Treatment summaries.
8. Diabetes in pregnancy: management from preconception to the postnatal period (NG3).
9. Diabetes in pregnancy: management from preconception – Recommendations chapter (NG3).
10. Metabolic regulation of erythrocyte development and disorders.
11. Fibroblast growth Factor-21 promotes ketone body utilization in neurons through activation of AMP-dependent kinase.
12. Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage.
13. Implications of impaired ketogenesis in fatty acid oxidation disorders.
14. Type 2 diabetes – Treatment summaries.
15. Revisiting the need for innovative oral hydration technologies.
16. Glucose stimulates calcium-activated chloride secretion in small intestinal cells.
17. Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption.
18. Glucose 40% w/v Concentrate for solution for infusion.

Frequently Asked Questions